Douglasville, GA, United States of America

Mike Powell

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Morehouse School of Medicine. Active years: 2017-2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mike Powell: Innovator in HIV Detection

Introduction

Mike Powell is a notable inventor based in Douglasville, GA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of HIV-related proteins. With a total of 3 patents to his name, Powell's work is paving the way for advancements in healthcare.

Latest Patents

One of Mike Powell's latest patents focuses on the detection of HIV-related proteins in urine. This innovative method involves isolating exosomes from a urine sample of a mammal and detecting the presence of HIV-specific biomarkers in the isolated exosomes. Additionally, the patent includes a method for diagnosing a mammal with an HIV-associated disease, specifically HIV-associated nephropathy. This groundbreaking work has the potential to improve early diagnosis and treatment options for individuals affected by HIV.

Career Highlights

Mike Powell is currently affiliated with Morehouse School of Medicine, where he continues to engage in research and development in the field of medical diagnostics. His dedication to innovation in healthcare is evident through his patents and ongoing research efforts.

Collaborations

Some of his notable coworkers include Gale W Newman and Akins Doherty. Their collaborative efforts contribute to the advancement of medical research and the development of new diagnostic methods.

Conclusion

Mike Powell's contributions to the field of HIV detection exemplify the impact of innovation in healthcare. His work not only enhances diagnostic capabilities but also holds promise for improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…